445 related articles for article (PubMed ID: 18507275)
1. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.
Dickson M; Plauschinat CA
Ethn Dis; 2008; 18(2):204-9. PubMed ID: 18507275
[TBL] [Abstract][Full Text] [Related]
2. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
Dickson M; Plauschinat CA
Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
[TBL] [Abstract][Full Text] [Related]
3. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.
Taylor AA; Shoheiber O
Congest Heart Fail; 2003; 9(6):324-32. PubMed ID: 14688505
[TBL] [Abstract][Full Text] [Related]
4. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population.
Shaya FT; Du D; Gbarayor CM; Frech-Tamas F; Lau H; Weir MR
J Natl Med Assoc; 2009 Jan; 101(1):34-9. PubMed ID: 19245070
[TBL] [Abstract][Full Text] [Related]
5. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
Kountz DS
J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
Chrysant SG
Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
[TBL] [Abstract][Full Text] [Related]
7. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
[TBL] [Abstract][Full Text] [Related]
8. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents.
Gerbino PP; Shoheiber O
Am J Health Syst Pharm; 2007 Jun; 64(12):1279-83. PubMed ID: 17563050
[TBL] [Abstract][Full Text] [Related]
9. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
Sapienza S; Sacco P; Floyd K; DiCesare J; Doan QD
Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study.
Poon I; Lal LS; Ford ME; Braun UK
Ann Pharmacother; 2009 Feb; 43(2):185-93. PubMed ID: 19193586
[TBL] [Abstract][Full Text] [Related]
11. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
12. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
[TBL] [Abstract][Full Text] [Related]
14. Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
Perrone V; Veronesi C; Gambera M; Nati G; Perone F; Tagliabue PF; Degli Esposti L; Volpe M
High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):399-404. PubMed ID: 31463886
[TBL] [Abstract][Full Text] [Related]
15. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and healthcare costs in hypertensive patients treated with a fixed-dose combination of amlodipine/valsartan.
Tung YC; Lin YS; Wu LS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2015 Jan; 17(1):51-8. PubMed ID: 25477188
[TBL] [Abstract][Full Text] [Related]
18. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
[TBL] [Abstract][Full Text] [Related]
19. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis.
Shenolikar RA; Balkrishnan R; Camacho FT; Whitmire JT; Anderson RT
Clin Ther; 2006 Aug; 28(8):1199-1207. PubMed ID: 16982297
[TBL] [Abstract][Full Text] [Related]
20. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
Brook RD; Kaciroti N; Bakris G; Dahlöf B; Pitt B; Velazquez E; Weber M; Zappe DH; Hau T; Jamerson KA
J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
